EP4135690
(S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMINE FOR TREATING, PREVENTING AND/OR MANAGING A NEUROLOGICAL AND/OR PSYCHIATRIC DISORDER
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
13.4.2021EP published:
25.3.2026EP application number:
21723520.9
EPO information:
European Patent Register
Max expiry date:
12.4.2041Expiry date:
12.4.2027Next due date:
30.4.2027
Title in English:
(S)-(4,5-DIHYDRO-7H-THIENO[2,3-C]PYRAN-7-YL)-N-METHYLMETHANAMINE FOR TREATING, PREVENTING AND/OR MANAGING A NEUROLOGICAL AND/OR PSYCHIATRIC DISORDERLanguage of the patent:
English
Timeline
Today
13.4.2021EP application
25.3.2026EP Publication
12.4.2027Expires
Owner
Name:
Sumitomo Pharma America, Inc.Address:
84 Waterford Drive, Marlborough, MA 01752, US
Inventor
Name:
BOWEN, Carrie A.Address:
Marlborough, Massachusetts 01752, US
Name:
HOPKINS, Seth CabotAddress:
Marlborough, Massachusetts 01752, US
Name:
SYNAN, Colleen M.Address:
Marlborough, Massachusetts 01752, US
Priority
Number:
202063009595 PDate:
14.4.2020Country:
US
Number:
202063039722 PDate:
16.6.2020Country:
US
Classification
Categories:
A61K 31/381, A61K 45/06, A61P 25/00, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/28, A61P 25/30
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 28.4.2026
Expires: 12.4.2027
Payer: Árnason Faktor ehf.